Impact Factor
4.57
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
7.61
5,422 total citations
h5-index
67
h5 depth signal
Cited share
92.1%
695 of 755
Total citations
5,422
Citation footprint
Metric signal
7.01
External metric anchor
Self-citation
6.4%
345 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
1,312
China
276
Hungary
231
Italy
200
United Kingdom
177
Citing Fields of Research
Aging & Longevity
1,120
Neurodegenerative Disorders
706
Neurosciences
242
Nutrition & Dietetics
220
Musculoskeletal Disorders
196
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,611
Articles tracked across the journal lifetime
Indexed publication set
755
695 cited publications
Last 12 months
655
54.6 publications/month
Open access share
63.8%
418 OA publications in the last year
Leading citing country
United States
1,312 citing publications
Leading citing field
Aging & Longevity
1,120 citing publications
Latest tracked publication
21 October 2026
10 recent records available
Coverage & Indexing History
v39, 2017-
v39n1, 2017-
Active Coverage
Research Focus & Classification
Indexed Subjects
Aging & Longevity
Neurodegenerative Disorders
Issuing & Sponsoring Bodies
sponsoring body
American Aging Association
Broad Categories
Geriatrics
Aging & Longevity
Neurodegenerative Disorders
Nutrition & Dietetics
DNA Damage
Neurosciences
Musculoskeletal Disorders
MeSH Descriptors
Aged
Aging
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1007/s11357-026-02610-3
Open DOI
Correction to: Henipaviruses: an expanding global public health concern?
02
03
04
DOI 10.1007/s11357-026-02584-2
Open DOI
Memantine in the treatment of dementia: a nationwide real-world analysis
05
DOI 10.1007/s11357-026-02593-1
Open DOI
An exploratory study of the effect of metformin on the whole blood transcriptome of nondiabetic older adults with age-related macular degeneration
Metformin has received increasing attention for benefits beyond blood glucose lowering. The purpose of this study was to identify changes in whole blood transcriptome from a course of metformin in a randomized trial (NCT02684578) of nond...
06
DOI 10.1007/s11357-026-02604-1
Open DOI
Obstructive sleep apnea is frequent in patients with Long COVID fatigue but is not significantly associated with alterations of quality of life and cognition
Neurologic manifestations of Long COVID, also called post-acute sequelae of SARS-CoV-2 infection (PASC), include fatigue, cognitive dysfunction, sleep disturbances, and headaches, which can be debilitating. Since these symptoms overlap w...
07
08
DOI 10.1007/s11357-026-02602-3
Open DOI
The influence of sensory function on walking stability in aging and falls through a head-movement perturbation model
09
DOI 10.1007/s11357-026-02585-1
Open DOI
Effect of telemedicine-delivered lifestyle interventions in older adults during the COVID-19 pandemic: a nationwide two-arm randomized trial (PROACTIVE-19)
Older adults are at increased risk of severe COVID-19 outcomes, yet randomized evidence on structured lifestyle interventions in this context remains limited. We aimed to evaluate the effects of a personalized lifestyle intervention on h...
10
Bibliographical & Catalog Notes
Official journal of the American Aging Association (AGE).